SangWook Yoon
5PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 02, 2023
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial.Geert D'Haens, Walter Reinisch, Stefan Schreiber
|Jun 03, 2022
Re-Routing Infliximab Therapy: Subcutaneous Infliximab Opens a Path Towards Greater Convenience and Clinical Benefit.Rieke Alten, Yoorim An, Dong-Hyeon Kim
|Mar 24, 2022
A Developer's Perspective on Clinical Evidence and Benefits for Rituximab Biosimilar Uptake, with a Focus on CT-P10.Dasom Choi, Soohyun Lee, Seungmin Kim
|Jan 13, 2022
Stepping Forward to the Next Level: Totality of Evidence for the First High-Concentration Adalimumab Biosimilar, CT-P17.Ombretta Viapiana, Soohyun Lee, SangWook Yoon
|Dec 06, 2021
An update on the adalimumab biosimilar landscape following the approval of the first high-concentration biosimilar.Enrico Fusaro, Patrick Durez, Johannes Wohlrab
Pageof 1
Frequent Collaborators
3 joint publications
Soohyun Lee
2 joint publications
Dong-Hyeon Kim
1 joint publications
Enrico Fusaro
1 joint publications
Patrick Durez
1 joint publications
Johannes Wohlrab
1 joint publications
Hubert Marotte
1 joint publications
Bruno Fautrel
1 joint publications
Dasom Choi
1 joint publications
Seungmin Kim
1 joint publications
Geert D'Haens
